As it had been hinting for several days, on Wednesday 11 November, the European Commission officially pledged to purchase at least 200 million doses of Pfizer-BioNTech’s Covid-19 candidate vaccine. The following day, it also promised limited access to the contents of contracts negotiated with the pharmaceutical industry.
The European Commission also announced the publication of guidance on antigenic testing “next week”.
Lack of transparency of agreements criticised
During a debate in...